The whipping post

3 of the Best Growth Stocks to Buy for Less Than $100 Right Now

Key Points

  • The stocks listed here have all declined by double-digits over the past year.

  • However, they still possess some attractive long-term growth opportunities.

  • At reduced valuations, they are much more compelling investment options to consider right now.

  • 10 stocks we like better than Netflix ›

Investing in an underperforming growth stock can be a great move for long-term investors. If a stock is trading at a low earnings multiple and there aren’t serious issues with the underlying business, it can be a sign that the market may have overreacted to company or even industry-related developments.

It’s these types of opportunities that can lead to significant gains down the road for investors who are willing to be patient and hang on. Three growth stocks trading below $100 that I believe are great buys right now are Netflix (NASDAQ:NFLX), Uber Technologies (NYSE:UBER), and Novo Nordisk (NYSE:NVO).

Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a “Double Down” signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same “Total Conviction” signal is flashing for a company 1/100th the size of Nvidia. Continue »

Smiling business couple viewing a smartphone while walking on a city sidewalk

Image source: Getty Images.

Netflix

Streaming giant Netflix has been struggling this year, amid questions about its future growth. The company is still generating double-digit growth, but with growing competition in the video streaming industry, the market appears less convinced of Netflix's future success.

As a result, Netflix's stock is down 17% this year, at one point falling as low as $65. On Friday, it closed at just over $78, and simply getting back to $100 would require a sizable 28% rally from its current level.

Netflix is, however, one of the better growth stocks to buy at under $100 as it provides investors with exposure to a top streaming company, which generates strong profit margins and has proven it can grow in many different ways, even as it has broadened its business to include live sports and gaming.

At 25 times its trailing earnings, Netflix is an excellent growth stock to buy today.

Uber Technologies

Shares of Uber are down around 18% over the past year. It has been an underperforming stock, but what's encouraging is that the business also has plenty of long-term growth opportunities to tap into.

In addition to continuing to grow its operations into more international markets, Uber has also partnered with multiple companies as it looks to be a big player in the robotaxi industry, recently launching a service in London, in partnership with a British technology company, Wayve.

The tech stock is trading at around $76, and its price-to-earnings (P/E) multiple of 17 looks incredibly attractive given how much potential room there still is for Uber's business to grow. In the trailing 12 months, the company has generated more than $55 billion in revenue, with its net income totaling a solid $9.6 billion.

See also  Had You Parked $5,000 in This Vanguard ETF When Warren Buffett Recommended It in 2014, Here's How Much You'd Have Today

Novo Nordisk

Healthcare giant Novo Nordisk has been struggling to win over investors as rival Eli Lilly has been dominating the GLP-1 drug market. However, with a top name in Ozempic and a higher-dose version of Wegovy showing it can potentially go toe-to-toe with Eli Lilly's leading product, there's still plenty of hope for Novo Nordisk stock to recover.

It's trading at around $47, and the stock is deeply discounted, as its P/E multiple is a lowly 11, suggesting that investors aren't giving it much of a chance. At such a low multiple, there's an appealing margin of safety that comes with the healthcare stock, and it may have plenty of room to rise higher if it can prove its doubters wrong.

The company has been facing challenges, largely due to rising competition. However, this is a stock that I think the market is dead wrong about, because Novo Nordisk still has some promising assets in its portfolio, and there is room for multiple drugs to perform well in the massive GLP-1 market.

Novo Nordisk's stock may be down, but I wouldn't count it out for the long run; now may be a great time to buy it while its valuation is incredibly low. As a bonus, it also offers a fairly high yield of around 3.9%.

Should you buy stock in Netflix right now?

Before you buy stock in Netflix, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Netflix wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $421,997!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,413,876!*

Now, it’s worth noting Stock Advisor’s total average return is 978% — a market-crushing outperformance compared to 213% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of September 8, 2026.

David Jagielski, CPA has positions in Novo Nordisk. The Motley Fool has positions in and recommends Eli Lilly, Netflix, and Novo Nordisk. The Motley Fool recommends Uber Technologies. The Motley Fool has a disclosure policy.

5 Stocks Our Experts Predict Could Double In the Next Year

By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.